Faculty profile

Andras Nagy

ResearcherLunenfeld-Tanenbaum Research InstituteUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Andras Nagy

Researcher

Lunenfeld-Tanenbaum Research Institute

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (7 CIHR, 1 NSERC), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2010.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

124

Publications

616

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Induced Pluripotent Stem Cells Reprogramming Alloaccept System Allogeneic Cell Transplant Cell-Based Therapy Fabkin Fatty Acid-Binding Protein 4 (Fabp4)Genome Editing

Latest papers

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.
Stem cell reports · 2026
Genome-edited safe and immune-evasive human pluripotent cells: Potential solution for allogeneic therapies.
Stem cell reports · 2026
Substrate stiffness dictates unique doxorubicin-induced senescence-associated secretory phenotypes and transcriptomic signatures in human pulmonary fibroblasts.
GeroScience · 2025

All 124 publications

Latest funding

Translating Cell Replacement Therapies for Type 1 Diabetes: Advancing Clinical Relevance
CIHR · 2025 · Nominated PI
$1,522,350
Generation of Non-Immunogenic Human Tracheal Grafts for Transplantation
CIHR · 2022 · Co-investigator
$757,350
Amelioration of Pulmonary Fibrosis Using Induced Progenitor-Like Cells via Reversal of Age-Related Stem Cell Decline
CIHR · 2018 · Co-investigator
$100,000

All 16 grants and awards

124 publications.

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Barry J, Abranches E, Baptista RP, Barry C, Brandsten C, Bruce K, Carpenter MK, Cavagnaro J, Collins L, Csaszar E, Dashnau J, de Villa D, Fynes K, Gabaldo M, Hao J, Harel-Adar T, Hei D, Henchcliffe C, Hidalgo-Simon A, Hollands J, Hursh D, Jackman S, Kelly K, Kim JH, Kim H, Kino-Oka M, Lakshmipathy U, Lamb T, Lazic SE, Loring JF, Ludwig TE, Mariappan I, Monville C, Mountford JC, Nagy A, Okano H, Pellegrini G, Persson A, Prutton K, Rasko JEJ, Sareen D, Sato Y, Shnaiderman A, Stacey G, Svendsen CN, Tomishima M, Trounson A, Viswanathan S, Wang S, Wydenbach K, Zhang A, Zylberberg C, Mosher JT, Bharti K

Stem cell reports2026

DOI: 10.1016/j.stemcr.2025.102784 PMID: 41576937

Genome-edited safe and immune-evasive human pluripotent cells: Potential solution for allogeneic therapies.

Tam V, Wong NCM, Poon ACH, Zhu M, Mei T, Kwok J, Chu P, Jong ED, Tang JK, Nagy A, Chan D

Stem cell reports2026

DOI: 10.1016/j.stemcr.2026.102850 PMID: 41791388

Substrate stiffness dictates unique doxorubicin-induced senescence-associated secretory phenotypes and transcriptomic signatures in human pulmonary fibroblasts.

Du H, Rose JP, Bons J, Guo L, Valentino TR, Wu F, Burton JB, Basisty N, Manwaring-Mueller M, Makhijani P, Chen N, Chang V, Winer S, Campisi J, Furman D, Nagy A, Schilling B, Winer DA

GeroScience2025

DOI: 10.1007/s11357-025-01507-x PMID: 39826027

A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.

Pavan C, Davidson KC, Payne N, Frausin S, Hunt CPJ, Moriarty N, Berrocal Rubio MÁ, Elahi Z, Quattrocchi AT, Abu-Bonsrah KD, Wang L, Clow W, Yang H, Pellegrini M, Wells CA, Thompson LH, Nagy A, Parish CL

Cell stem cell2025

DOI: 10.1016/j.stem.2025.03.008 PMID: 40209717

Engineered mesenchymal stromal cells with interleukin-1beta sticky-trap attenuate osteoarthritis in knee joints.

Kim C, Li B, Nakamura S, Neely EJ, Rockel JS, Oussenko T, Zhang P, Kapoor M, Nagy A

Frontiers in cell and developmental biology2025Senior author

DOI: 10.3389/fcell.2025.1559155 PMID: 40264709

Application of gene therapy in osteoarthritis.

Li Y, Li B, Nagy A, Kim C

Connective tissue research2025

DOI: 10.1080/03008207.2025.2533332 PMID: 40717471

GDF11-secreting cell transplant efficiently ameliorates age-related pulmonary fibrosis.

Guo L, Duchesneau P, Jong ED, Sawula E, Li C, Waddell TK, Nagy A

Molecular therapy : the journal of the American Society of Gene Therapy2025Senior author

DOI: 10.1016/j.ymthe.2025.07.003 PMID: 40676836

Microfluidic chip systems for characterizing glucose-responsive insulin-secreting cells equipped with FailSafe kill-switch.

Izadifar M, Massumi M, Prentice KJ, Oussenko T, Li B, Elbaz J, Puri M, Wheeler MB, Nagy A

Stem cell research & therapy2024Senior author

DOI: 10.1186/s13287-024-04059-7 PMID: 39696686

Substrate Stiffness Dictates Unique Doxorubicin-induced Senescence-associated Secretory Phenotypes and Transcriptomic Signatures in Human Pulmonary Fibroblasts.

Du H, Rose JP, Bons J, Guo L, Valentino TR, Wu F, Burton JB, Basisty N, Manwaring-Mueller M, Makhijani P, Chen N, Chang V, Winer S, Campisi J, Furman D, Nagy A, Schilling B, Winer DA

bioRxiv : the preprint server for biology2024

DOI: 10.1101/2024.11.18.623471 PMID: 39605579

The Circadian Clock of Müller Glia Is Necessary for Retinal Homeostasis and Neuronal Survival.

Pickel L, Kim SJ, Hacibekiroglu S, Nagy A, Lee J, Sung HK

The American journal of pathology2024

DOI: 10.1016/j.ajpath.2024.07.017 PMID: 39147235

Translating Cell Replacement Therapies for Type 1 Diabetes: Advancing Clinical Relevance

Nominated PICIHR2025Project Grant

Principal investigators: Nagy, Andras

Keywords: Alloaccept System; Allogeneic Cell Transplant; Cell-Based Therapy; Fabkin; Fatty Acid-Binding Protein 4 (Fabp4); Genome Editing; Pluripotent Stem Cells; Safecell System; Stem Cell Islets; Type 1 Diabetes Mellitus

$1,522,350

Generation of Non-Immunogenic Human Tracheal Grafts for Transplantation

Co-investigatorCIHR2022Project Grant

Principal investigators: Karoubi, Golnaz; Haykal, Siba

Keywords: Airway Patches; Airway Regeneration; Biological Scaffolds; Cell Therapy; Designer Cells; Epithelial Cells; Human Induced Pluripotent Stem Cells; Immunology; Trachea; Transplantation

$757,350

Amelioration of Pulmonary Fibrosis Using Induced Progenitor-Like Cells via Reversal of Age-Related Stem Cell Decline

Co-investigatorCIHR2018Project Grant

Principal investigators: Waddell, Thomas K

Keywords: Aging; Lung; Pulmonary Fibrosis; Rejuvenation; Reprogramming; Stem Cells

$100,000

Amelioration of Pulmonary Fibrosis Using Induced Progenitor-Like Cells via Rejuvenation of Stem Cells

Co-investigatorCIHR2018Project Grant

Principal investigators: Waddell, Thomas K

Keywords: Aging; Lung; Pulmonary Fibrosis; Rejuvenation; Reprogramming; Stem Cells

$634,950

Advanced Bioreactors for Evaluation and Systematic Optimization of Decellularization and Recellularization of the Lung and Trachea

Co-investigatorCIHR2017Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Amon, Cristina; Keating, Armand; Waddell, Thomas K

Keywords: Airway Regeneration; Biological Scaffolds; Bioreactor; Decellularization; In Silico Modelling; Lung; Recellularization; Systematic Process Optimization; Tissue Engineering; Trachea

$291,825

Tissue engineering an intervertebral disc replacement

Co-investigatorCIHR2015Operating Grant

Principal investigators: Kandel, Rita A

Keywords: In Vitro; In Vivo; Intervertebral Disc; Phenotype; Regenerative Medicine; Stem Cells; Tissue Engineering

$768,657

Canada Research Chair Tier 1

Nominated PICIHR2014Canada Research Chairs - CIHR Funded - Tier 1

Principal investigators: Nagy, Andras

Keywords: Crc

$1,400,000

Somatic cell reprogramming and therapeutics

Nominated PICIHR2014Foundation Grant

Principal investigators: Nagy, Andras

Keywords: Arthritis; Cell Fate; Degenerative Disease; Diabetes; Gene Therapies; Immune Tolerance; Induced Pluripotent Stem Cells; Regenerative Medicine; Reprogramming; Stem Cell-Based Therapies

$2,616,629

Directing Cellular Identity to Move Towards Progenitor Cell Therapies

Nominated PICIHR2012Canada-Japan CEEHRC Teams in Epigenetics of Stem Cells

Principal investigators: Nagy, Andras

Keywords: Cell Based Therapy; Cell Therapy Safety; Disease Models; Duchenne Muscular Dystrophy; Epigenetics; Gene Correction; In Vitro Differentiation; Induced Pluripotent Stem Cells; Reprogramming; Rett Syndrome

$2,000,000

Programming reactive astrocytes as a tool for ameliorating brain injury and promoting CNS repair and regeneration

SupervisorCIHR2010CIHR Fellowship

Principal investigators: Faiz, Maryam

Keywords: Astroctyte; Cloning; Cns; Dedifferentiation; Epigenetic Profiling; Ips/Reprogramming; Neural Stem/Progenitor Cell; Stroke; Transgenic

$90,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Andras Nagy

Research

Latest papers

Latest funding

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Genome-edited safe and immune-evasive human pluripotent cells: Potential solution for allogeneic therapies.

Substrate stiffness dictates unique doxorubicin-induced senescence-associated secretory phenotypes and transcriptomic signatures in human pulmonary fibroblasts.

A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.

Engineered mesenchymal stromal cells with interleukin-1beta sticky-trap attenuate osteoarthritis in knee joints.

Application of gene therapy in osteoarthritis.

GDF11-secreting cell transplant efficiently ameliorates age-related pulmonary fibrosis.

Microfluidic chip systems for characterizing glucose-responsive insulin-secreting cells equipped with FailSafe kill-switch.

Substrate Stiffness Dictates Unique Doxorubicin-induced Senescence-associated Secretory Phenotypes and Transcriptomic Signatures in Human Pulmonary Fibroblasts.

The Circadian Clock of M&#xfc;ller Glia Is Necessary for Retinal Homeostasis and Neuronal Survival.

Frequent collaborators

Janet Rossant

Chi-Chung Hui

Derek van der Kooy

Maryam Faiz

James Ellis

Wei Wang

Golnaz Karoubi

Graham Collingridge

Rod Bremner

Louis Lefebvre

Sowmya Viswanathan

Nika Shakiba

Amira Klip

Kyoung-Han Kim

Brian Cox

Chen Wang

Jason Moffat

Mohit Kapoor

Hong Han

Laura Donaldson

Carl Shen

Martin Post

Mei Zhen

Gordon Keller

Gelareh Zadeh

Cynthia Hawkins

Mansoor Husain

Christine Bear

Angelo Canty

Laurent Briollais

Mick Bhatia

The Circadian Clock of Müller Glia Is Necessary for Retinal Homeostasis and Neuronal Survival.